CBO's recent score tallied temporary PAMA delay as a cost rather than a savings, potentially making future delays less likely but possibly raising the chances of permanent reform.

The digital immunoassay platform is designed to detect and quantify proteins at the single-molecule level in blood, serum, or plasm. The platform includes the HD-X Simoa Immunoassay Analyzer, which ...

The German startup is developing ultrasensitive lateral flow diagnostic tests that incorporate DNA origami signal amplification.

Last week, readers were most interested in a story about FDA approving Cleveland Diagnostics' prostate cancer test.

The test could potentially deliver noninvasive results in less than one minute through analysis of exhaled volatile organic compounds.

Uniogen's progress toward clinical commercialization aligns with larger internal goals of bringing cancer diagnostics to market, with a specific focus on women's health.

The test helps diagnose infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis.

The test, which will use Iso-PAS technology, will be developed by Nipro of Japan in collaboration with other companies, institutes, and nonprofit organizations.

The medical center will use PathAI's AISight Dx image management system to evaluate algorithms for a variety of applications.

NEW YORK – Cancer detection company Freenome said Friday that it plans to go public on the Nasdaq through a merger with publicly traded special purpose acquisition company Perceptive Capital Solutions ...

NEW YORK – Swiss diagnostic firm Testmate Health plans to leverage a new partnership with hospital system Intermountain Health to further validate and improve access to the company's urine test for ...